Delivery Order SPE2DB20D1109-SPE2DB23FN71U
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $3,328.64 firm fixed-price delivery order is for the medical supply "BRIDION 200 MG/2 ML VIAL 2ML" and has a completion date of November 7, 2023. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,738.63 Firm Fixed Price Delivery Order contract is for the supply of BRIDION 200 MG/2 ML VIAL 2ML, a medical product, with a completion date of February 25, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Bridion 500 mg/5 ml vials. The $19,386.60 firm fixed-price delivery order has a completion date of November 15, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,515.59 firm fixed-price delivery order is for the supply of BRIDION 200 MG/2 ML VIAL 2ML, a medical product, with a completion date of March 10, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $51,615.19 firm fixed price delivery order from the Defense Logistics Agency (DLA) for the supply of BRIDION 200 MG/2 ML VIAL 2ML medical products. The contract has an ultimate completion date of July 9, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $62,165.38, is for the delivery of BRIDION 200 MG/2 ML VIAL 2ML, a medical product. The contract is a Firm Fixed Price Delivery Order, with a completion date of September 9, 2022. This contract award is not designated with a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,621.22 firm fixed-price delivery order is for the medical product BRIDION 200 MG/2 ML VIAL 2ML. The contract has an ultimate completion date of February 18, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,029.48 firm fixed-price delivery order is for the supply of BRIDION 200 MG/2 ML VIAL 2ML medical products. The contract has an ultimate completion date of April 14, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,426.90 firm fixed-price delivery order contract is for the supply of the medication BRIDION 200 MG/2 ML VIAL 2ML. The contract has an ultimate completion date of January 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award, valued at $22,734.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order to support the supply of BRIDION 200 MG/2 ML VIAL 2ML medical products. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FN71UDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of BRIDION 200 MG/2 ML VIAL 2ML medical supplies. The $4,205.38 firm fixed-price delivery order has a completion date of March 14, 2023 and is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which maintains a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract serves as a primary vehicle for the company to efficiently deliver essential medications, devices, and other critical medical commodities to the Department of Defense and Department of Veterans Affairs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 3/13/23 |